Tafamidis in patients with severe heart failure due to transthyretin amyloidosis cardiomyopathy: improved long-term survival

被引：1
|
作者：
Tubben, Alwin [1 ,2 ]
Nienhuis, Hans L. A. [2 ,3 ]
van der Meer, Peter [1 ,2 ]
机构：
[1] Univ Med Ctr Groningen, Dept Cardiol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Med Ctr Groningen, Amyloidosis Ctr Expertise, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷 / 11期
关键词：
D O I：
10.1002/ejhf.3053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2065 / 2066
页数：2
相关论文
共 50 条
  • [41] LONG-TERM SURVIVAL PATIENTS WITH ACUTE AND SEVERE RENAL-FAILURE DUE TO MULTIPLE-MYELOMA
    PASQUALI, S
    CASANOVA, S
    ZUCCHELLI, A
    ZUCCHELLI, P
    CLINICAL NEPHROLOGY, 1990, 34 (06) : 247 - 254
  • [42] Muscle strength as a predictor of long-term survival in severe congestive heart failure
    Hülsmann, M
    Quittan, M
    Berger, R
    Crevenna, R
    Springer, C
    Nuhr, M
    EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (01) : 101 - 107
  • [43] Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
    Coelho, Teresa
    Maia, Luis F.
    da Silva, Ana Martins
    Cruz, Marcia W.
    Plante-Bordeneuve, Violaine
    Suhr, Ole B.
    Conceicao, Isabel
    Schmidt, Hartmut H. -J.
    Trigo, Pedro
    Kelly, Jeffery W.
    Labaudiniere, Richard
    Chan, Jason
    Packman, Jeff
    Grogan, Donna R.
    JOURNAL OF NEUROLOGY, 2013, 260 (11) : 2802 - 2814
  • [44] Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
    Teresa Coelho
    Luis F. Maia
    Ana Martins da Silva
    Márcia W. Cruz
    Violaine Planté-Bordeneuve
    Ole B. Suhr
    Isabel Conceiçao
    Hartmut H.-J. Schmidt
    Pedro Trigo
    Jeffery W. Kelly
    Richard Labaudinière
    Jason Chan
    Jeff Packman
    Donna R. Grogan
    Journal of Neurology, 2013, 260 : 2802 - 2814
  • [45] Long- term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction
    Drachman, Brian
    Damy, Thibaud
    Hanna, Mazen
    Wang, Rong
    Angeli, Franca S.
    Garcia-Pavia, Pablo
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S4 - S4
  • [46] Outpatient Worsening Heart Failure in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B Trial
    Fontana, Marianna
    Maurer, Mathew S.
    Gillmore, Julian D.
    Bender, Shaun
    Aldinc, Emre
    Eraly, Satish A.
    Jay, Patrick Y.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 85 (07) : 753 - 761
  • [47] Improved survival with revascularisation compared to medical therapy in patients with heart failure due to ischaemic cardiomyopathy
    Senior, R
    Kaul, S
    Lahiri, A
    CIRCULATION, 1998, 98 (17) : 430 - 430
  • [48] Long-Term Survival Outcomes after Heart Transplantation in Patients with Chagas Cardiomyopathy
    Nattiv, J.
    Liu, G. S.
    Banankhah, P.
    Genyk, P. A.
    Kingsford, P. A.
    Li, J. P.
    Chand, R. R.
    Vucicevic, D.
    Pandya, K.
    Rahman, J.
    Wolfson, A. M.
    DePasquale, E. C.
    Vaidya, A. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S481 - S482
  • [49] Natriuretic peptides, atrial fibrillation, and survival in patients with transthyretin cardiomyopathy receiving tafamidis treatment
    Bampatsias, Dimitrios
    Wardhere, Abdirahman
    Santos, Alfonsina Mirabal
    Cuomo, Margaret
    Teruya, Sergio
    Maurer, Mat
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S160 - S161
  • [50] Autonomic dysfunction and prediction of long term survival in transthyretin amyloidosis
    Algalarrondo, V.
    Antonini, T.
    Theaudin, M.
    Chemla, D.
    Benmalek, A.
    Lacroix, C.
    Catstaing, D.
    Cauquil, C.
    Dinanian, S.
    Eliahou, L.
    Samuel, D.
    Adams, D.
    Le Guludec, D.
    Slama, M. S.
    Rouzet, F.
    EUROPEAN HEART JOURNAL, 2016, 37 : 569 - 570
12345